Business Context and Reporting Period
GoodRx Holdings, Inc. filed a Form 8-K on July 10, 2024, reporting the entry into a material definitive agreement. The filing details the Sixth Amendment to the Company's First Lien Credit Agreement, executed by GoodRx, Inc., an indirect wholly-owned subsidiary.
Key Financial Metrics and Debt Structure
- New Term Loan Facility: Established a $500.0 million 2024 Term Loan Facility with a maturity date of July 10, 2029.
- Revolving Credit Facility: Extended the maturity date of $88.0 million of the existing $100.0 million facility to April 10, 2029. The remaining $12.0 million terminates on July 11, 2025.
- Refinancing Activity: Repaid all existing term loans immediately prior to the effective date using proceeds from the new facility and $167.2 million in cash on hand.
- Interest Rates: The 2024 Term Loans bear interest at SOFR plus 3.75% (with a 0.00% floor) or an alternate base rate plus 2.75%.
- Original Issue Discount: The 2024 Term Loans were funded at 99.0% of the principal amount.
- Financial Covenant: Requires maintaining a First Lien Net Leverage Ratio not exceeding 8.2 to 1.0 if revolving credit utilization exceeds a specified threshold.
Material Changes Versus Prior Period
The primary material change is the restructuring of the Company's debt obligations. The Company replaced its existing term loans with a new $500.0 million facility, extending the maturity horizon to 2029. Additionally, the maturity of the majority of the revolving credit facility was extended by several years. The transaction involved a significant cash outflow of $167.2 million from the Company's balance sheet to settle prior obligations and associated fees.
Guidance, Risks, and Covenants
- Covenants: The agreement includes restrictions on indebtedness, liens, fundamental changes, investments, asset sales, stock repurchases, and dividends. GoodRx is restricted from making dividend payments or loans to the parent company, subject to limited exceptions.
- Prepayment Terms: Mandatory prepayments are required in instances of asset dispositions, casualty events, non-permitted debt issuances, and annual excess cash flow. A 1.00% prepayment premium applies to voluntary prepayments made prior to January 10, 2025.
- Events of Default: Lenders may terminate commitments and require immediate repayment upon an event of default, including automatic acceleration in the event of bankruptcy.
- Forward-Looking Statements: The filing includes standard disclaimers regarding risks associated with indebtedness and the uncertainty of future performance.
Investor Verification Checklist
- Verify the exact amount of cash on hand remaining after the $167.2 million outflow used to repay existing term loans.
- Confirm the current utilization rate of the Revolving Credit Facility to assess if the 8.2 to 1.0 leverage ratio covenant is currently triggered.
- Review the full text of Exhibit 10.1 for specific definitions of "annual excess cash flow" and other mandatory prepayment triggers.
- Assess the impact of the 1.00% prepayment premium on the Company's ability to refinance or repay debt before January 2025.